PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 29, 2026Journal of Patient-Reported Outcomes0 citationsOpen Access

Gastrointestinal and respiratory symptom reporting by race among cancer patients in an RSM Program

SOSandra C. OlisakweJDJoud El DickLDLuqin Deng

Key Points

  • This study aims to evaluate racial differences in moderate to severe gastrointestinal and respiratory symptom reporting among cancer patients using remote symptom monitoring.
  • Conducted a retrospective cohort study with 924 cancer patients enrolled in an RSM program.
  • Patients self-reported gastrointestinal and respiratory symptoms weekly for six months using the PRO-CTCAE tool.
  • Used a generalized linear mixed-effects Poisson log-link model to compare symptom reporting between Black and White patients at two time intervals.
  • No significant differences in moderate/severe GI symptoms between Black (18%) and White patients (20%; RR: 0.92, 95% CI: 0.76–1.09).
  • No significant differences in respiratory symptoms (Black: 5%, White: 4%; RR: 1.25, 95% CI: 0.91–1.70).
  • Lower frequency of reported moderate to severe symptoms in months 4 to 6 compared to months 0 to 3, with a 29% reduction for GI and 26% for respiratory symptoms.

Abstract

Abstract Background Gastrointestinal (GI) and respiratory symptoms are common among patients undergoing cancer treatment, yet little is known about the symptom burdens and management by race. Remote Symptom Monitoring (RSM) with electronic Patient-Reported Outcomes (ePROs) enhances symptom tracking and intervention; however, its impact on racial disparities in symptom reporting remains unclear. Objective This study examined racial differences in moderate to severe symptom reporting among patients enrolled in an ePRO-based RSM program, described how the frequency of reported symptoms differed across early and later periods of enrollment, and characterized patient engagement with the program. Methodology We conducted a retrospective cohort study of 924 cancer patients enrolled in an RSM program at a large academic medical center. Patients self-reported GI (constipation, diarrhea, decreased appetite, nausea, vomiting) and respiratory (cough, shortness of breath) symptoms weekly for six months. Symptoms were categorized as moderate/severe versus none/mild using the PRO-CTCAE grading tool. A generalized linear mixed-effects Poisson log-link model, adjusted for demographic and clinical factors, compared the frequency of moderate/severe symptom reporting between Black and White patients at 0 to 3 and 4 to 6 months post RSM enrolment. Results We observed no significant differences in reported moderate/severe GI (Black: 18%, White: 20%; RR: 0.92, 95% CI: 0.76–1.09) or respiratory symptoms (Black: 5%, White: 4%; RR: 1.25, 95% CI: 0.91–1.70) by race. Across all patients, the proportion of surveys reporting moderate to severe symptoms was lower in months 4 to 6 than in months 0 to 3, with a 29% lower frequency for GI and 26% lower for respiratory symptoms. Consistent responding was associated with lower reported symptom burden. Conclusion Our findings show no significant racial differences in reported moderate to severe GI or respiratory symptoms within this RSM program. Whether the program itself reduces symptom burden cannot be determined from this single-group design.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Olisakwe et al. (2026) studied this question.

synapsesocial.com/papers/6a69a26dc8da07d9defa5d77https://doi.org/10.1186/s41687-026-01165-3
Ask AI
Helpful
Bookmark
Share
View Full Paper